H.R. 6895, the "Defense Production and Active Pharmaceutical Ingredients Act," seeks to amend the National Defense Authorization Act for Fiscal Year 2023. The proposed change would broaden federal support for bioindustrial manufacturing processes to include the manufacturing of:
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2023-12-22 | IntroReferral | Referred to the House Committee on Armed Services. | House floor actions |
| 2023-12-22 | IntroReferral | Introduced in House | Library of Congress |